Carvedilol prevents impairment of the counterregulatory response in recurrently hypoglycaemic diabetic rats.

Rawad FarhatEliane de Santana-Van VlietGong SuLevi NeelyThea BenallyOwen Chan

Published in: Endocrinology, diabetes & metabolism (2021)

Our data suggest that carvedilol may be useful in preventing impairments of the sympathoadrenal response and the development of hypoglycaemia unawareness during recurring episodes of hypoglycaemia in diabetic animals.

Keyphrases

diabetic rats
type diabetes
oxidative stress
electronic health record
big data
artificial intelligence
data analysis